Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype

被引:43
作者
Sossi, V
Giuli, A
Vitali, T
Tiziano, F
Mirabella, M
Antonelli, A
Neri, G
Brahe, C
机构
[1] Catholic Univ Rome, Ist Genet Med, I-00168 Rome, Italy
[2] Catholic Univ Rome, Dept Neurol, Rome, Italy
[3] Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy
关键词
spinal muscular atrophy; survival motor neuron gene; exon skipping; mutations;
D O I
10.1038/sj.ejhg.5200599
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autosomal recessive spinal muscular atrophy (SMA) is a common motor neuron disease caused by absence or mutation in the survival motor neuron (SMN1) gene. SNM1 and a nearly identical copy, SMN2, encode identical proteins, but SMN2 only produces a little full length protein due to alternative splicing. The level of functional SMN protein and the number of SMN2 genes correlate with the clinical phenotype ranging from severe to very mild. Here, we report on premature termination mutations in SMN1 exon 3 (425del5 and W102X) which induce skipping of the mutated exon. The novel nonsense mutation W102X was detected in two patients with a relatively mild phenotype who had only two copies of the SMN2 gene, a number that has previously been found associated with the severe form of SMA. We show that the shortened transcripts are translated into predicted in frame protein isoforms. Aminoglycoside treatment suppressed the nonsense mutation in cultured cells and abolished exon skipping, Fibroblasts from both patients show a high number of nuclear structures containing SMN protein (gems). These findings suggest that the protein isoform lacking the exon 3 encoded region contributes to the formation of the nuclear protein complex which may account for the milder clinical phenotype.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 33 条
[1]   Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice [J].
Barton-Davis, ER ;
Cordier, L ;
Shoturma, DI ;
Leland, SE ;
Sweeney, HL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) :375-381
[2]   Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I [J].
Brahe, C ;
Clermont, O ;
Zappata, S ;
Tiziano, F ;
Melki, J ;
Neri, G .
HUMAN MOLECULAR GENETICS, 1996, 5 (12) :1971-1976
[3]   Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly:: implications for spinal muscular atrophy [J].
Buhler, D ;
Raker, V ;
Lührmann, R ;
Fischer, U .
HUMAN MOLECULAR GENETICS, 1999, 8 (13) :2351-2357
[4]   Genomic variation and gene conversion in spinal muscular atrophy: Implications for disease process and clinical phenotype [J].
Campbell, L ;
Potter, A ;
Ignatius, J ;
Dubowitz, V ;
Davies, K .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (01) :40-50
[5]   Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems [J].
Charroux, B ;
Pellizzoni, L ;
Perkinson, RA ;
Shevchenko, A ;
Mann, M ;
Dreyfuss, G .
JOURNAL OF CELL BIOLOGY, 1999, 147 (06) :1181-1193
[6]  
Clermont O, 1997, AM J HUM GENET, V61, pA329
[7]   The survival motor neuron protein in spinal muscular atrophy [J].
Coovert, DD ;
Le, TT ;
McAndrew, PE ;
Strasswimmer, J ;
Crawford, TO ;
Mendell, JR ;
Coulson, SE ;
Androphy, EJ ;
Prior, TW ;
Burghes, AHM .
HUMAN MOLECULAR GENETICS, 1997, 6 (08) :1205-1214
[8]   CHAOS IN THE CLASSIFICATION OF SMA - A POSSIBLE RESOLUTION [J].
DUBOWITZ, V .
NEUROMUSCULAR DISORDERS, 1995, 5 (01) :3-5
[9]   SURVIVAL MOTOR-NEURON GENE TRANSCRIPT ANALYSIS IN MUSCLES FROM SPINAL MUSCULAR-ATROPHY PATIENTS [J].
GENNARELLI, M ;
LUCARELLI, M ;
CAPON, F ;
PIZZUTI, A ;
MERLINI, L ;
ANGELINI, C ;
NOVELLI, G ;
DALLAPICCOLA, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 213 (01) :342-348
[10]   The Schizosaccharomyces pombe protein Yab8p and a novel factor, Yip1p, share structural and functional similarity with the spinal muscular atrophy-associated proteins SMN and SIP1 [J].
Hannus, S ;
Bühler, D ;
Romano, M ;
Seraphin, B ;
Fischer, U .
HUMAN MOLECULAR GENETICS, 2000, 9 (05) :663-674